US EditionENTOD Pharmaceuticals launches Myopia therapy and collagen serum in new R&D push - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
ENTOD Pharmaceuticals launches Myopia therapy and collagen serum in new R&D push - Express Pharma
ENTOD Pharmaceuticals has introduced new research-led treatments in ophthalmology and dermatology, driven by its Mumbai-based R&D centre. These developments include what the company calls the world’s first eye drop to slow myopia progression in children aged 6 to 12 and a collagen-based transdermal serum designed for layered skin regeneration. The company’s prescription-only eye drop is aimed at addressing childhood myopia, which ENTOD Pharmaceu…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
